] b may be indicative of ischemia or hypoxemia, it may also be a "normal" physiological response to exertion. In response to "all-out" maximal exertion lasting 30-120 seconds, peak [La - ] b values of ≈15-25 mM may be observed 3-8 minutes postexercise. In response to progressive, incremental exercise, [La - ] b increases gradually at first and then more rapidly as the exercise becomes more intense. The work rate beyond which [La - ] b increases exponentially [the lactate threshold (LT)] is a better predictor of performance than VO 2max and is a better indicator of exercise intensity than heart rate; thus LT (and other valid methods of describing this curvilinear [La - ] b response with a single point) is useful in prescribing exercise intensities for most diseased and nondiseased patients alike. H + -monocarboxylate cotransporters provide the primary of three routes by which La -transport proceeds across the sarcolemma and red blood cell membrane. At rest and during most exercise conditions, whole blood 
Introduction
Bl ood lactate concentration ([La - ] b ) is one of the most often measured parameters during clinical exercise testing as well as during performance testing of athletes. Because measurements of an elevated [La -] b may be used to evaluate an underlying pathology during a routine stress test (coronary artery disease, chronic airway obstruction, chronic renal failure, metabolic impairment), [1] [2] [3] [4] [5] [6] [7] and also to prescribe appropriate exercise intensities for different patient populations, [8] [9] [10] [11] [12] it has been recommended that [La - ] b analysis be added to normal stress testing measurements. response to exercise if a patient exceeds the work rate at which La -can be removed from the blood as quickly as it enters the blood 14, 15 and (2) elevations of [La - ] b are not necessarily indicative of either ischemia or hypoxemia. 16 The current paradigm for La -metabolism is embodied in the cell-to-cell lactate shuttle, which was originated in 1984 by George Brooks. 17 Since its introduction, this hypothesis has been repeatedly supported by studies using a wide variety of experimental approaches. It posits that La -formation, and its subsequent distribution throughout the body, is a major mechanism whereby the coordination of intermediary metabolism in different tissues, and different cells within those tissues, can be accomplished. 16 The importance of La -as a carbohydrate fuel source is underscored by the fact that during moderate intensity exercise, blood La -flux may exceed blood glucose flux. 
Response to Progressive, Incremental Exercise
Perhaps most often studied during exercise testing is the response to progressive, incremental exercise in which the work rate is increased at regular intervals (typically, 1-4 minutes) until the subject reaches volitional exhaustion. In this type of exercise, [La - ] b increases gradually at first and then more rapidly as the exercise becomes more intense (Figure 1) . In 1930, Owles 20 was the first to report this "threshold" effect when he measured his own [La - ] b in response to walking at varying intensities. Figure 1 illustrates the [La -] b response to a typical progressive, incremental exercise test protocol. Subjects performed unloaded pedaling at 60 rpm for 4 minutes on a standard laboratory cycle ergometer. Each subsequent minute, the work rate was increased by 30 W. Blood samples were taken via a forearm venous catheter during the last 30 seconds of each work rate and whole blood samples were analyzed using the criterion/reference enzymatic method. 21 Warming each subject's hand with warm air and wrapping a heating pad around the subject's arm permitted sampling of "arterialized" blood (PO 2 ≥70 mm Hg). 22 Because venous blood drains from different tissue beds (some being net La -consumers; others being net La -producers), [La - ] b differs depending on the site of venous sampling. Thus, an arterial sample is preferred. Due to difficulty with obtaining an arterial sample, "arterialized" blood is often used to approximate arterial [La -] b . "Arterialization" involves heating the hand in order to increase blood flow sufficiently to decrease the transit time of blood through the capillaries so that the venous concentration of La -is hardly changed from the arterial concentration. These "arterialized" samples provide [La - ] b values that are representative of arterial values. 22 A primary issue concerning data of this nature is determination of a single value that represents an attempt to describe the curvilinear [La -] b profile. 23 Among the best known of these are the lactate threshold (LT), the D max method of determining the LT (LT D ), and the onset of blood lactate accumulation (OBLA), 23 although numerous other approaches exist.
The traditional determination of LT is shown in Figure 1 determination of LT. For example, the visual LT method may incorporate the use of a log-log transformation. 25 The visual approach as applied to either the untransformed La -response or the log-log approach is often assisted by using a ruler to draw two lines of best fit to the data and then selecting the intersection of the two lines as the LT. Another refinement used on either raw data or log-log data involves the use of a computer program to determine all possible combinations of two straight line fits to the data; the two-line combination that minimizes the total sum of squares for fitting all data is then used to derive the LT (from the intersection of these two lines). The visual method (Figure 2A ) and a log-log transformation ( Figure 2B ) are illustrated in Figure 2 . More recently, the lactate response to submaximal exercise has been described by the maximal lactate steady state (MLSS). MLSS is defined as the highest intensity of exercise that can be performed while maintaining a constant ] b values at MLSS has been reported for different subjects, from as low as 1.5 mM to almost 7 mM. However, the average value is ≈3.7 mM. 
Response to Maximal Effort Exercise
For the subject represented in Figure 1 45 Oxidation is the most likely route of La -removal by skeletal muscle, although La -may also be used to synthesize glycogen. 23 As the metabolic rate increases during exercise, La -oxidation by skeletal muscles and the heart also increases. [45] [46] [47] The fact that the heart is an active consumer of La -has been frequently overlooked. Figure 8 shows the relationship between LT and long-distance running performance in young endurance athletes. 57 Similar results have been observed by other investigators. 10, 31, 32, [54] [55] [56] 58, 59 Furthermore, aerobic training has been shown to improve LT, with a concomitant improvement in endurance performance or even middle-distance performance. 57 A "good" or "trained" runner will exhibit a higher LT and a lower [La -] b than a "poor" or "untrained" runner at any absolute intensity above resting. Figure 9 depicts differences that may be seen between a "good runner" and a "poor runner" in terms of the [La - ] b response to progressive incremental exercise. 57 Measuring a patient's [La -] b has clinical value not only because it can be used to evaluate an underlying pathology, 1,2,5 but also because it circumvents the use of heart rate or expired gases as indices of training intensity. Patients with a chronic airway obstruction 60 or a cardiac pathology 10 may present with expired gases and/or heart rates that are not necessarily indicative of exercise intensity; however, an individual's LT can be used to accurately evaluate and prescribe exercise intensity for most diseased and nondiseased patients alike. Frequently, LT is used to prescribe exercise intensity for diabetic patients, as they often have cardiac limitations and/or microcirculatory pathologies that hasten the transition to significant La -accumulation. 8, 11, 12 In 1983, Coyle and co-workers 10 found that patients with ischemic heart disease had disproportionately high endurance capacities when compared to their O 2max 63 In this case, a system designed to cotransport La -and H + from the plasma into the RBCs could aid in establishing a gradient between the plasma and the interstitial fluid and enhance the efflux of La -and H + from the exercising muscles. 62, 64 Indeed the transport of La -across the RBC membrane proceeds by the same three distinct pathways that are employed in transport across the sarcolemma, all shown schematically in Figure 11: (1) nonionic diffusion of undissociated HLa (≈5-12%); (2) the inorganic anion exchange system utilizing the "band 3" protein, often referred to as the "band 3 system" (≈5-15%); and (3) MCT1, the primary pathway of La -transport across the human RBC membrane (≈75-90%).
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At physiological pH levels, less than 0.5% of the total HLa + La -is in the undissociated HLa form. Accordingly, ≈5-12% may appear quite large for the contribution of undissociated HLa transport. However, it should be noted that HLa diffuses across plasma membranes readily so that even a small concentration gradient can contribute significantly to overall transport. At higher La -concentrations, the MCT carriers become saturated, so the diffusion component becomes a greater percentage of total transport. The exception occurs immediately after intense, "all-out" exercise, when the rate of La -release into the blood from the exercising muscles is apparently too rapid for the La -transport systems of the RBC membrane to achieve equilibrium. Figure 12 ). This issue is complicated by the fact that different La -analyzers measure either plasma or content corrections are not performed in either case.) However, as described later, the blood sample type being analyzed (whole blood or plasma) is often not so clear when an automatic analyzer is used.
Several studies since the early 1990s have compared various analyzers to each other. [76] [77] [78] These studies are inherently weak in comparison to studies that include a criterion/reference enzymatic method. Other studies do not clearly indicate that some of the discrepancy between analyzers is the result of one analyzer measuring whole blood [La -] while another is measuring plasma [La -]. Perhaps the best paper to date regarding different La -analyzers is that by Medbø and colleagues. 19 In their experiments, 800 blood or plasma samples were measured with at least two different methods or instruments. Altogether, almost 3000 single measurements were performed.
As an example, consider comparisons between Yellow Springs Instruments, Inc. (YSI) (Yellow Springs, Ohio) analyzers and the criterion/reference enzymatic method. Because YSI analyzers assume that a known and constant amount of blood is used for each measurement, the analyzers are equipped with pipettes for inserting a known volume of sample. According to YSI analyzer manuals, only La -in plasma is measured unless the blood samples are hemolyzed.
There was a strong linear correlation (r = 0.995) between the YSI 23L and the criterion/reference enzymatic method, but on average the values obtained with the YSI 23L were 22% lower. This result may be due to the YSI instrument analyzing nonhemolyzed blood, thus measuring only the La -in the plasma, but reporting the La -based on the total volume of blood injected. When hemolyzed blood was analyzed with the YSI 1500, there was a strong linear correlation with the criterion/reference enzymatic method. However, values obtained with this instrument were 20% higher than those obtained via the criterion/ reference enzymatic method. Because the same sample type is being compared in this case, the error must be in the measurement by the instrument. 19 A second YSI 1500 was also compared to the criterion/reference enzymatic method. This yielded another strong linear correlation with values averaging 5% higher than the criterion/ reference values, but with no significant difference from the line of identity. Overall, five YSI analyzers were tested and there was variability among the group. 19 A comparison of the Dr. Lange miniphotometer LP8+ (Dr. Bruno Lange GmbH; Berlin, Germany) versus the criterion/reference enzymatic method is illustrated whole blood [La - ] values and it is sometimes difficult to know which is being measured.
It is worth noting that the aforementioned relationship would be altered for patients with anemia or polycythemia due to the differing contributions of RBCs versus plasma in such samples. As an approximation, the ratio of whole blood [La - ] to plasma [La - ] might be expected to vary from about 63% at a hematocrit of 55% to about 81% at a hematocrit of 25%.
Analyzers and Analysis
Once we are aware of the differences between plasma [La -] and whole blood [La - ], how does this affect analysis? First, and most obvious, is the simple point that it is imperative to know whether plasma or whole blood is being analyzed. When the criterion/reference enzymatic method is used (as is typical during laboratory experiments), this is obvious. For example, after drawing a blood sample, an aliquot of the whole blood would be added to ice-cold, 4.2% perchloric acid to lyse the RBCs and deproteinize the sample. Following centrifugation, an aliquot of the supernatant would be analyzed via the criterion/reference enzymatic method. 19 However, if plasma [La - ] was being measured, the blood sample would be centrifuged first and then an aliquot of the plasma would be added to the ice-cold, 4.2% perchloric acid. From this brief description, it should be clear that the sample type being analyzed (either whole blood or plasma) with this method is unequivocal. (Typically water in Figure 13A . For this analyzer, blood is hemolyzed in a reagent solution, processed, and read from the miniphotometer. Values for the LP8+ were on average 26% higher than those of the criterion/reference enzymatic method. 19 The Accusport (Boehringer Mannheim, East Sussex, UK) was also compared to the criterion/reference enzymatic method. According to the manufacturer, the Accusport only measures La -in the plasma, even though a drop of whole blood is applied to the reagent strip. Built-in equations convert the measured plasma values to whole blood values. The Accusport showed two types of deviation relative to the criterion/reference method. First, the Y intercept was close to 1 mM (versus an ideal intercept of 0 mM). Finally, Figure 13B displays a comparison of the Lactate Pro (Arkray, Inc., Kyoto, Japan) versus the criterion/ reference enzymatic method. The manufacturer of the Lactate Pro provides no information on how this instrument accounts for La -inside of RBCs. However, on the basis of its performance, it appears that it must lyse the RBCs in whole blood samples. Samples are collected by inserting a La -strip into a calculator-sized instrument and then touching the strip to a drop of blood. The sample is drawn into the strip by capillary action. Figure 13B shows that values obtained with the Lactate Pro were highly correlated with the criterion/reference method and averaged 12% higher. Furthermore, for values less than 6 mM, the Lactate Pro did not show systematic error from the criterion/reference method; this supports its use for La -threshold testing. When plasma samples were measured with the Lactate Pro (rather than whole blood directly from a patient), values below 10 mM were up to 10% higher than the criterion/reference method values. However, plasma values were too low for samples above 10 mM. When different Lactate Pro instruments were analyzed, they were found to be consistent with each other. Overall, Medbø and colleagues 19 concluded that the Lactate Pro was the best of the four instruments examined.
To summarize, it is imperative to know what type of sample is being measured. RBCs, plasma, and whole blood all have different values from each other even in blood that has complete equilibrium between plasma and RBCs. Plasma and whole blood [La - ] values are not interchangeable and errors will result if this is ignored. Furthermore, when using automated analyzers, the type of sample presented does not necessarily determine what is being measured (plasma or whole blood). All analyzers differ from the criterion/reference enzymatic standard by varying degrees, 19 and their precision, accuracy, and bias should be taken into account when interpreting the measurements made with them. ] b may be indicative of ischemia or hypoxemia, it may also be a "normal" physiological response to exertion.
Conclusion

